Traitement systémique du cancer de l'endomètre avancé

Youssef Tazi, Patricia Pautier, Catherine Lhommé

    Résultats de recherche: Contribution à un journalArticleRevue par des pairs

    1 Citation (Scopus)

    Résumé

    Endometrial cancer has generally a good prognosis when it is diagnosed at an early stage but remains incurable at an advanced stage (recurrent or metastatic) with only few therapeutic options. Hormone therapy is the treatment of choice in case of slowly progressive disease with a tumor expressing hormonal receptors due to its favorable safety profile. Taxanes, anthracyclines and platinum compounds are the most active chemotherapy agents with greater response rates when they are combined at the price of a significant toxicity. Targeted therapies based on a better understanding of tumor biology are being evaluated with some promising results.

    Titre traduit de la contributionSystemic therapy for advanced endometrial cancer
    langue originaleFrançais
    Pages (de - à)93-97
    Nombre de pages5
    journalBulletin du Cancer
    Volume99
    Numéro de publication1
    Les DOIs
    étatPublié - 1 janv. 2012

    mots-clés

    • Chemotherapy
    • Endometrial cancer
    • Hormonal therapy
    • Targeted therapy

    Contient cette citation